Home › NDC Lookup › RxCUI directory › RxCUI 213197

Becaplermin 0.0001 MG/MG Topical Gel [Regranex] — RxCUI 213197

RxNorm drug concept · Semantic branded drug
RxCUI 213197 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI213197
Official nameBecaplermin 0.0001 MG/MG Topical Gel [Regranex]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asRegranex 0.01 % Topical Gel; Regranex 0.0001 MG/MG Topical Gel; Regranex 100 MCG per GM Topical Gel
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Becaplermin Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Regranex helps your body heal a diabetic ulcer that isn't closing on its own. It contains a growth factor — a protein signal — that tells your body's repair cells to move into the...
  • What exactly is Regranex supposed to do for my ulcer?
  • The amount depends on the size of your ulcer — specifically its length and width. Your doctor or wound care provider will do that calculation for you and show you how much to squee...
  • How do I know how much gel to use each time?
📖 Read our full Becaplermin Topical guide →

🕸️ Concept Web — How Becaplermin 0.0001 MG/MG Topical Gel [Regranex] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Becaplermin 0.0001 MG/MG Topical Gel [Regranex] RxCUI 213197

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Becaplermin 115238
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Regranex 219603
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Becaplermin Topical Gel 385096
    • Becaplermin Topical Product 1155689
    • Becaplermin Topical Gel [Regranex] 370427
    • Regranex Topical Product 1180070
    • Topical Gel 346286
    • Topical Product 1151122
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Brand-Name Concepts

  • Becaplermin 0.0001 MG/MG [Regranex] SBDC · 573119
  • Becaplermin Topical Gel [Regranex] SBDF · 370427
  • Regranex Topical Product SBDG · 1180070
  • Regranex BN · 219603

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 213197 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
85822-0734-15 15 g in 1 TUBE (85822-734-15) Regranex Gel 0.01% LRM Therapeutics, LLC 2025-06-30
Observed labelers: LRM Therapeutics, LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.